Gapping down
In reaction to earnings/guidance:
- DNUT -8.1%, PLCE -5.6%, JKHY -4.7%, TGT -1.8%, ADI -1.4%, TJX -1.4%
Other news:
- ASLE -13.5% (selling shareholders to offer 4.25 mln shares in secondary offering)
- OPCH -6.9% (OPCH announces 11 mln share offering by WBA)
- SNY -5.2% (is discontinuing the global clinical development program of amcenestrant, an investigational oral selective estrogen receptor degrader)
- IMAB -4.5% (IMAB amends license and collaboration agreement with ABBV)
- BE -4.5% (priced its underwritten public offering of 13 mln shares of Class A common stock at $26.00/share)
- OSH -3.4% (files for stock offering by selling shareholders)
- GSK -2.5% (FDA accepts New Drug Application for GSK's momelotinib for the treatment of myelofibrosis)
- NOVA -2.1% (pricing of upsized offering of $500 million of 2.625% convertible senior notes)
- DDOG -2% (announces expanded monitoring for Microsoft SQL Server and Microsoft Azure database platforms)
- VRDN -2% (announces the pricing of an upsized underwritten public offering with gross proceeds of ~$270 mln)
- FSM -1.5% (announces the voluntary resignation of Paul Criddle from the position of Chief Operating Officer - West Africa effective September 30, 2022)
- HYZN -1.3% (to delay 10-Q filing)
- SHEL -1.2% (to shut Gulf of Mexico crude pipelines, Odyssey and Delta, for two weeks, according to Reuters)